Death rates from cancer continue to decline in the United States
Molecular tumor subtyping offers more accurate prediction of long-term breast cancer outcomes.
Report features 76 studies; highlights new approaches to cancer care, new treatments
Unless the federal budget sequester is resolved, the impacts to oncology and biomedical research in 2014 could be long-lasting and severe.
Discussions with patients about fertility preservation prior to their cancer treatments are critical.
Author: Barbara Ann Burtness, MD
H.R. is a 70-year-old woman who presented to her dentist with a 2-year history of ...
Author: Sandra Puri Cuellar, PharmD, BCOP
Upon laboratory testing, SL, a 64-year-old female diagnosed with Philadephia chromosome–positive (Ph+) ALL, was ...
Dr. Farma and his colleagues present this unique case study.
Editorial Advisory Board member Mark Socinski, MD, discusses key clinical insights brought to light by the POINTBREAK trial of maintenance therapy for NSCLC.
Barbara Ann Burtness, MD
Steven Cohen, MD
E. David Crawford, MD
Don S. Dizon, MD, FACP
Jeffrey M. Farma, MD
Sergio A. Giralt, MD
Todd Morgan, MD
Edith A. Perez, MD
Neal D. Shore, MD, FACS
Mark A. Socinski, MD
Martin Tallman, MD
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|